Alnylam Pharmaceuticals, Inc. (ALNY)
359.27
+0.01
(+0.00%)
USD |
NASDAQ |
Jan 16, 16:00
358.96
-0.31
(-0.09%)
After-Hours: 20:00
Alnylam Pharmaceuticals Total Liabilities (Quarterly): 4.618B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Insmed, Inc. | 1.415B |
| Pfizer Inc. | 115.64B |
| Biogen, Inc. | 11.00B |
| Bristol Myers Squibb Co. | 78.29B |
| Vertex Pharmaceuticals, Inc. | 7.544B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.852B |
| Shareholders Equity (Quarterly) | 233.89M |
| Debt to Equity Ratio | 11.86 |
| Current Ratio | 2.541 |
| Net Debt Paydown Yield | -0.02% |